AI English summary of an SEC filing — figures as filed

Boston Scientific said Charles J. Dockendorff informed the company on February 9, 2025 that he will not stand for re-election at the 2025 Annual Meeting of Stockholders.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Feb 12, 2025Period of report Feb 9, 2025Summary published (UTC) Oct 16, 2026

Key points

AI summary

Boston Scientific said Charles J. Dockendorff informed the company on February 9, 2025 that he will not stand for re-election at the 2025 Annual Meeting of Stockholders.
The company said Dockendorff has served on the Board of Directors since April 2015 and currently serves on the Audit Committee and the Risk Committee.
Boston Scientific said Dockendorff will continue to serve as a director and in his committee roles until the 2025 Annual Meeting, and that his decision not to stand for re-election is not the result of any disagreement with the company.
The company said the Board and the Nominating and Governance Committee regularly review the size and composition of the Board and will continue to evaluate whether adding directors following Dockendorff's departure is in the best interest of the company.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Boston Scientific Says Dockendorff Will Not Stand for Re-Election at 2025 Annual Meeting

Boston Scientific said Charles J. Dockendorff informed the company on February 9, 2025 that he will not stand for re-election at the 2025 Annual Meeting of Stockholders.

Source · Based on the filing body and exhibits

Board Tenure and Committee Roles

The company said Dockendorff has served on the Board of Directors since April 2015 and currently serves on the Audit Committee and the Risk Committee.

Source · Based on the filing body and exhibits

Continuing Service Until 2025 Annual Meeting

Boston Scientific said Dockendorff will continue to serve as a director and in his committee roles until the 2025 Annual Meeting, and that his decision not to stand for re-election is not the result of any disagreement with the company.

Source · Based on the filing body and exhibits

Review of Board Size and Composition

The company said the Board and the Nominating and Governance Committee regularly review the size and composition of the Board and will continue to evaluate whether adding directors following Dockendorff's departure is in the best interest of the company.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.